4-Chloro-7-fluoroquinazoline is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various biologically active compounds. Its primary application lies in the development of anticancer drugs, particularly tyrosine kinase inhibitors, which target specific enzymes involved in cancer cell growth and proliferation. The compound’s structure allows for further modifications to enhance drug efficacy and selectivity. Additionally, it serves as a building block in the creation of other quinazoline derivatives, which are explored for their potential in treating diseases such as hypertension, inflammation, and bacterial infections. Its versatility in medicinal chemistry makes it a valuable component in drug discovery and development processes.